SAYPHA® VOLUME

Where can I buy this product?

SAYPHA® VOLUME (without Lidocaine) may be available for purchase through Health Supplies Plus by licensed medical practitioners holding a valid medical license. First-time buyers can register an online account by providing required professional information, including medical license verification and a valid shipping address. Account verification is typically completed within 2 business hours, after which you can purchase medical supplies at competitive wholesale pricing. Registered members may also be eligible for volume discounts and receive dedicated customer service support.

Product Information

What is SAYPHA® VOLUME (without Lidocaine)?

SAYPHA® VOLUME is a sterile, viscoelastic, injectable gel implant composed of cross-linked hyaluronic acid (HA) of non-animal origin, manufactured by Croma-Pharma GmbH (Austria). It is formulated using Croma’s proprietary S.M.A.R.T. (Supreme Monophasic and Reticulated Technology) process, described by the manufacturer as resulting in a highly structured, homogenous gel suitable for volumizing.

This formulation typically contains 23mg/mL of cross-linked hyaluronic acid and is designed as a volumizing filler intended for injection into the deep dermis or subcutaneous layer to correct deep facial wrinkles, folds, and restore facial volume. This specific formulation does not contain lidocaine, suitable for patients with sensitivities or when alternative anesthesia is preferred.

Storage: Store according to manufacturer guidelines, typically between 2°C and 25°C (36°F and 77°F). Do not freeze. Protect from light and moisture.

Authenticity: Health Supplies Plus guarantees that SAYPHA® products sourced are authentic from the manufacturer or authorized distributors.

Note: For professional use only by trained and licensed practitioners in jurisdictions where its use is legally permitted.

How does SAYPHA® VOLUME work?

SAYPHA® VOLUME utilizes the S.M.A.R.T. technology to create a monophasic, cross-linked HA gel designed for significant volume restoration and correction of deep tissue deficits. When injected into the deep dermis or subcutaneous tissue, the viscoelastic gel physically occupies space, lifting tissues, filling deep folds (like severe nasolabial folds or marionette lines), and augmenting facial contours (e.g., cheeks, chin).

The manufacturer claims the S.M.A.R.T. process ensures specific rheological properties suitable for volumizing while aiming for smooth integration and structural support. The cross-linked HA resists rapid degradation, providing durable correction. The hydrophilic nature of HA also contributes to maintaining tissue hydration.

Treatment results are intended to be visible immediately. The manufacturer suggests a duration of effect lasting approximately 8 to 12 months, though individual results will vary significantly based on patient factors, injection depth, volume, and area treated. Adequate anesthesia (e.g., topical, nerve block) should be employed as this formulation is lidocaine-free.

Indications for Use

SAYPHA® VOLUME is typically indicated for adults seeking correction of deep facial lines and significant volume restoration:

• Correction of deep wrinkles and folds (e.g., severe nasolabial folds, marionette lines).
• Facial volume augmentation (e.g., cheeks, chin).
• Facial contouring requiring substantial volume and lift.
• Correction of facial lipoatrophy or deep scars.

Primary Benefits

• Designed for correcting deep wrinkles and restoring significant facial volume.
• Utilizes S.M.A.R.T. technology for a structured, monophasic gel.
• Suitable for deep dermis / subcutaneous injection for contouring and augmentation.
• Provides immediate volumizing results.
• Results claimed to last 8-12 months.
• Lidocaine-free formulation for specific patient/practitioner needs.

Side Effects and Safety Information

Common side effects expected with deep HA filler injections include temporary, injection-site related reactions:

• Swelling (can be significant initially)
• Bruising
• Redness
• Tenderness or Pain (may be more pronounced without lidocaine)
• Itching
• Firmness or Lumps/Bumps
• Inflammation

Severe Adverse Events:
As with any dermal filler injection, particularly those involving deeper placement or significant volume, there are risks of more serious complications. Practitioners must be prepared to manage adverse events. Potential severe adverse events include:

• Vascular Occlusion (VO): Accidental injection into a blood vessel can obstruct blood flow, potentially leading to tissue necrosis (tissue death), scarring, or (in rare cases involving facial arteries) blindness or stroke. Prompt recognition and management protocols are crucial.
• Severe allergic reactions or hypersensitivity to HA
• Inflammation, infection, or abscess formation
• Granuloma or persistent nodule formation
• Migration of filler
• Prolonged pain or numbness
• Herpetic eruptions (cold sores) in susceptible individuals
• Hematomas

Any signs of vascular compromise, infection, hypersensitivity, or persistent adverse reactions require immediate medical evaluation.